IDXX Financial Facts
Product revenue: 191.33MResearch and development: 19.41M
See Full Income Statement
Total IDEXX Laboratories, Inc. stockholders' equity: 585.94M
Current portion of deferred revenue: 13.64M
See Full Balance Sheet
IDEXX Labs (IDXX) Earnings
|
Expand Research on IDXX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +8.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/29/22 | Q222 | N/A | $1.56 | N/A | N/A | $865.3M | N/A | N/A | N/A | ||
| 5/4/22 |  |
Q122 | $2.27 | $2.26 | +$0.01 | $837M | $839.72M | N/A |  | | Details |
| 2/2/22 | |
Q421 | $1.89 | $1.71 | +$0.18 | $801M | $784.27M | N/A | | | Details |
| 11/2/21 | |
Q321 | $2.03 | $1.90 | +$0.13 | $810M | $798.16M | N/A | | | Details |
| 7/30/21 | |
Q221 | $2.34 | $2.04 | +$0.30 | $826M | $782.99M | N/A | | | Details |
| 5/4/21 | |
Q121 | $2.35 | $1.71 | +$0.64 | $778M | $738.43M | N/A | | | Details |
| 2/2/21 | |
Q420 | $2.01 | $1.39 | +$0.62 | $720.94M | $680.03M | N/A | | | Details |
| 10/29/20 | |
Q320 | $1.69 | $1.42 | +$0.27 | $722M | $669.45M | N/A | | | Details |
